A major advance in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This vital malignant protector protein is frequently inactivated in many types of malignancies, causing https://socialicus.com/story7469756/mini-antibodies-restore-tumor-suppressor-p53-new-potential-pathway-for-malignant-therapy